Biotechnology News

September 4, 2012

OSAKA, Japan & BEDMINSTER, N.J.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502, “Takeda”) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP, “NPS”), jointly announced today that the European Commission (EC) has granted European...

September 4, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix announced top line results from a clinical study: novel inhaled therapeutic, PUR118, demonstrated anti-inflammatory efficacy and was well-tolerated in chronic obstructive pulmonary disease.

September 4, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix announced the appointment of Robert Clarke, Ph.D., as Chief Executive Officer.

September 4, 2012

YOKOHAMA, Japan--(BUSINESS WIRE)--The Netzsch Analyzing & Testing division and Bruker Corporation today announced jointly that Netzsch Japan K.K. has acquired Bruker’s Thermal Analysis instruments business in Japan. Together with the well-...

September 4, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following...

September 4, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentations at two upcoming investment conferences. Illumina will webcast its presentation at the Morgan Stanley Global Healthcare...

September 4, 2012

LONDON--(BUSINESS WIRE)--New study “Future Horizons in the Global Immunodiagnostics Market: Supplier Shares and Sales Forecasts” elaborated by Venture Planning Group has been recently published by Market Publishers Ltd.

September 4, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA® (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney...

September 4, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies (“HemCon”), a leading global developer of advanced medical technologies and products, announced receiving an additional U.S. regulatory clearance for the antimicrobial hemostatic IV...

September 4, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (KYTHERA) today announced the completion of enrollment in two pivotal U.S. and Canadian Phase III clinical trials of ATX-101, a potential first-in-class injectable facial aesthetic...

September 4, 2012

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare, the healthcare business of GE (NYSE: GE), today introduced KUBioTM, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money...

September 4, 2012

LONDON--(BUSINESS WIRE)--Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for...

September 4, 2012

TORRANCE, Calif.--(BUSINESS WIRE)--The CEO of Phenomenex, Fasha Mahjoor, successfully rappelled/abseiled down 87 floors of the Shard in London, Europe's tallest building, to raise money for The Outward Bound Trust educational charity.

September 3, 2012

AARHUS, Denmark--(BUSINESS WIRE)--CLC bio announces the acquisition of Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of protein-ligand interactions, and much more.

September 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference

September 3, 2012

INGELHEIM AM RHEIN, Germany--(BUSINESS WIRE)--For medical media outside the USA and UK Coinciding with the annual European Respiratory Society Congress, ERS 2012, SPIRIVA® (tiotropium), the first once-daily long-acting inhaled anticholinergic...

August 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera obtains UK approval to initiate clinical G-202 trial in prostate cancer.

August 31, 2012

CAMBRIDGE, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (“Agios”) and The University of Pennsylvania (“Penn”) today announced that, in connection with the resolution of litigation announced earlier today, Agios and Penn...

August 31, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma announced that Francis Bullock, and Kevin Koch have decided not to stand for reelection to its Board of Directors and that David Snitman intends to resign from the Board of Directors.

August 31, 2012

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) announced today that it has completed the acquisition of the majority of the Movianto Group, a European third party logistics business.

August 31, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

August 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--IDRA to present at Rodman conference September 10

August 31, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics is relocating its corporate headquarters to Atlanta, GA.

August 31, 2012

RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--Boehringer Ingelheim and Pfizer Inc (NYSE: PFE) announced today three scientific data presentations will take place at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria,...

August 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Vitrolife AB (publ)(STO:VITR) will take place on Monday September 24, 2012, at 3 p.m. in the company’s premises at Gustaf Werners gata 2 in Gothenburg....

August 31, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: The Probi (STO:PROB) probiotic company, which is listed on the Nasdaq OMX Nordic Exchange Stockholm, has gained a new industrial shareholder in the German company Symrise. Symrise has acquired a...

August 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine: (STO:AERO.B) With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by exercise of options...

August 31, 2012

SYDNEY--(BUSINESS WIRE)--GenesisCare shareholders have voted unanimously in favour of affiliates of Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, "KKR") entering into an agreement whereby KKR will own a 49.6 per cent of...

August 30, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from Baird’s 2012 Healthcare Conference in New York. Norbert Bischofberger, PhD, Gilead’s Executive Vice...

August 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) announced today that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at three upcoming investor conferences. Stifel...

August 30, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Stifel Nicolaus Annual Healthcare Conference in Boston on Thursday, September 6, 2012 at 8:35 a.m. ET. The presentation will be available as a live...

August 30, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Baird 2012 Health Care Conference on Thursday, Sept. 6, 2012, at 11:20 a.m. EDT (4:20 p.m. BST) in New York City. In...

August 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) will be hosting a conference call to discuss the U.S. Food and Drug Administration (FDA) approval of LINZESS™ at 4:00 p.m....

August 30, 2012

MADISON, Wis.--(BUSINESS WIRE)--Six Wisconsin bioscience companies have been selected as the winners of BioForward’s 2012 Emerging Company Showcase. The showcase is part of the 2012 Bioscience Vision Summit, being held on Sept 12.